Earnings Feed
Start Free
Home/Filings/4/0001179110-16-026417
4//SEC Filing

OSIRIS THERAPEUTICS, INC. 4

Accession 0001179110-16-026417

CIK 0001360886operating
View on SEC.govCompany Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 5:20 PM ET

Size

22.0 KB

Accession

0001179110-16-026417

Insider Transaction Report

Form 4
Period: 2016-06-09
OSIRIS THERAPEUTICS, INC.OSIR
Montgomery Bobby Dwayne
Chief Business Officer
Transactions
  • Disposition to Issuer

    Incentive Stock Options (right to buy)

    2016-06-09$12.39/sh+6,250$77,438→ 35,000 total
    Exercise: $12.39From: 2018-04-21Exp: 2024-04-21→ Common Stock (6,250 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$18.40/sh+3,125$57,500→ 28,750 total
    Exercise: $18.40From: 2018-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$12.39/sh+6,250$77,438→ 41,250 total
    Exercise: $12.39From: 2017-04-21Exp: 2024-04-21→ Common Stock (6,250 underlying)
  • Disposition to Issuer

    Incentive Stock Options (right to buy)

    2016-06-09$18.40/sh+3,125$57,500→ 31,875 total
    Exercise: $18.40From: 2017-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$7.39/sh+2,500$18,475→ 23,125 total
    Exercise: $7.39From: 2017-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$7.39/sh+2,500$18,475→ 20,625 total
    Exercise: $7.39From: 2018-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$7.39/sh+2,500$18,475→ 18,125 total
    Exercise: $7.39From: 2019-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$7.39/sh+2,500$18,475→ 15,625 total
    Exercise: $7.39From: 2020-03-04Exp: 2026-03-04→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2016-06-09$18.40/sh+3,125$57,500→ 25,625 total
    Exercise: $18.40From: 2019-03-06Exp: 2025-03-06→ Common Stock (3,125 underlying)
Footnotes (1)
  • [F1]Unvested incentive stock options that were forfeited concurrent with the Reporting Person's separation from the company, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he separated from the company will remain exercisable for 90 days from the departure date.

Documents

1 file

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

→
Entity typeoperating
IncorporatedMD

Related Parties

1
  • filerCIK 0001360886

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:20 PM ET
Size
22.0 KB
View on SEC.gov